AstraZeneca PLC

AstraZeneca PLC American Depositary Shares is the U.S.-traded representation of AstraZeneca PLC, a global biopharmaceutical company focused on the discovery, development, manufacture, and commercialization of prescription medicines. The company serves major therapeutic areas including oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, and rare diseases, with a portfolio that spans both established treatments and specialty medicines. AstraZeneca also operates in biologics and small-molecule research, supporting a broad pipeline of medicines used across hospitals, clinics, and specialty care settings. Its business model centers on developing therapies for patients and supplying healthcare systems and providers worldwide. Founded in 1999 and headquartered in Cambridge, United Kingdom, AstraZeneca is a significant participant in the global pharmaceutical market through its diversified drug portfolio and research-driven operations.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.

Employees

94,300

Headquarters

Cambridge, United Kingdom

Website

www.astrazeneca.com